Do omega-3 fatty acids alter HDL particle remodeling and function?

Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), significantly alter the structural and functional properties of high-density lipoprotein (HDL) particles. This shifts the clinical focus from absolute HDL cholesterol concentrations to qualitative particle functionality.

Membrane lipidomic and ApoA-I remodeling

• Dietary omega-3 intake directly modifies HDL membrane lipid composition by incorporating EPA and DHA into HDL phospholipids (such as phosphatidylcholines). This alters acyl-chain packing and increases membrane fluidity.
• This lipidomic modification enhances the exchangeability of Apolipoprotein A-I (ApoA-I) on the lipoprotein surface.
• Concurrently, altered ApoA-I kinetics and conformation drive the remodeling and maturation of HDL, shifting the distribution toward larger, lipid-enriched particles.

Cholesterol efflux and cellular transport

• Phospholipid remodeling within both cell membranes and HDL particles directly modulates cholesterol efflux pathways mediated by cellular transporters, including ABCA1 and SR-BI.
• While laboratory and ex vivo models demonstrate that omega-3 enrichment influences transporter-specific efflux dynamics, human clinical evidence regarding overall cholesterol efflux capacity (CEC) remains highly context-dependent, with some trials showing no net change in clinical CEC.

Bottom line

• Omega-3 fatty acids drive HDL particle remodeling and functional optimization through a tripartite mechanism: altering membrane lipid composition, increasing ApoA-I exchangeability, and modulating cell-to-lipoprotein cholesterol efflux pathways.